10 sources
Health Insiders relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
[1] GLP-1 Agonists for Weight Loss: What You Need to Know: https://www.forbes.com/health/weight-loss/glp-1-agonists/
[2] Association of Glucagon-Like Peptide 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events: A Systematic Review and Network Meta-Analysis: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00494-6/fulltext
[3] Efficacy of GLP-1 RA Approved for Weight Management in Patients with or Without Diabetes: A Narrative Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063254/
[4] Regulation of Glucose Homeostasis by GLP-1: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159612/
[5] Effects of GLP-1 on Appetite and Weight: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119845/
[6] Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial: https://www.nature.com/articles/s41591-022-02026-4
[7] Once-Weekly Semaglutide in Adults with Overweight or Obesity: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
[8] Obesity: Risk Factors, Complications, and Strategies for Sustainable Long?Term Weight Management: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088226/
[9] Pharmacologic Treatment of Overweight and Obesity in Adults: https://www.ncbi.nlm.nih.gov/books/NBK279038/
[10] Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787121/
Was This Article Helpful ?
- Yes
- No
Rating Snapshot: